---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293620964.md"
description: "Niki BioSolutions shares are trading higher after the company announced its subsidiary, DiamiR Biosciences, entered into agreement to provide Progressive Medical Research with Apolipoprotein E genotyping services."
datetime: "2026-07-23T12:04:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293620964.md)
  - [en](https://longbridge.com/en/news/293620964.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293620964.md)
generator: "portal-rs"
---

# 

Niki BioSolutions shares are trading higher after the company announced its subsidiary, DiamiR Biosciences, entered into agreement to provide Progressive Medical Research with Apolipoprotein E genotyping services.

### Related Stocks

- [NIKI.US](https://longbridge.com/en/quote/NIKI.US.md)

## Related News & Research

- [Kala Bio signs LOI for exclusive US distribution of Virotek ophthalmology genetic tests](https://longbridge.com/en/news/297646733.md)
- [NeuroGT Announces FDA Clearance of Investigational New Drug Application for NGT-104, an AAV9 Gene Replacement Product for MPS IIIB](https://longbridge.com/en/news/297947685.md)
- [Circio boosts circVec gene therapy data and secures funding runway to 2030](https://longbridge.com/en/news/297552739.md)
- [Taysha Gene Therapies highlights TSHA-102 Rett gene therapy path toward BLA submission in corporate presentation](https://longbridge.com/en/news/297550820.md)
- [09:11 ETBioViva Announces U.S. Patent for Klotho Gene Therapy Targeting Age-Related Cognitive Decline](https://longbridge.com/en/news/297657999.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**